Using computer simulations to compare pertussis vaccination strategies in Australia.

Using computer simulations to compare pertussis vaccination strategies in Australia.

High levels of notified pertussis in adolescents and adults, persisting severe disease (hospitalization and deaths) in infants despite high childhood immunization coverage, together with the availability of adult-formulated pertussis vaccines, have made alternate strategies for vaccine control of pe...

Bibliografski detalji
Glavni autori:	Hethcote, H, Horby, P, McIntyre, P
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia
od: Helen E Quinn, i dr.
Izdano: (2011-09-01)

Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.
od: Patricia Campbell, i dr.
Izdano: (2012-01-01)

Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000.
od: McIntyre, P, i dr.
Izdano: (2002)

Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000.
od: Horby, P, i dr.
Izdano: (2003)

Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
od: Connie Lam, i dr.
Izdano: (2014-04-01)

A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods.
od: Horby, P, i dr.
Izdano: (2005)

Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis
od: I. A. Alekseeva, i dr.
Izdano: (2018-02-01)

Measles vaccination coverage among five‐year‐old children: implications for disease elimination in Australia
od: Glenda L. Lawrence, i dr.
Izdano: (2003-08-01)

New features of pertussis vaccination
od: A. P. Cherdantsev, i dr.
Izdano: (2020-06-01)

Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
od: I. A. Alekseeva, i dr.
Izdano: (2021-03-01)

Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.
od: Hassen Mohammed, i dr.
Izdano: (2018-01-01)

Emergence of pertactin-deficient pertussis strains in Australia can be explained by models of vaccine escape
od: Duleepa Jayasundara, i dr.
Izdano: (2020-06-01)

Safety of pertussis vaccines for adolescents
od: M. P. Kostinov, i dr.
Izdano: (2020-10-01)

The Role of the Aceullular Pertussis Vaccine and the Comeback of 'Pertussis Pete'?
od: John M Conly, i dr.
Izdano: (2001-01-01)

Pertussis Toxin: A Key Component in Pertussis Vaccines?
od: Kelsey A. Gregg, i dr.
Izdano: (2019-09-01)

Acellular Pertussis Vaccines and Pertussis Resurgence: Revise or Replace?
od: Clara Maria Ausiello, i dr.
Izdano: (2014-07-01)

Population-based estimates of the effectiveness of pneumococcal vaccination in Australia
od: Heather Gidding, i dr.
Izdano: (2017-04-01)

Comparative genomics of whole-cell pertussis vaccine strains from India
od: Shweta Alai, i dr.
Izdano: (2020-05-01)

Vacina acelular contra pertússis para adolescentes Acellular pertussis vaccine for adolescents
od: Aroldo P. de Carvalho, i dr.
Izdano: (2006-07-01)

Analysis of <it>Bordetella pertussis </it>pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
od: Slack Andrew T, i dr.
Izdano: (2006-03-01)

Antenatal influenza and pertussis vaccination in Western Australia: a cross-sectional survey of vaccine uptake and influencing factors
od: Donna B. Mak, i dr.
Izdano: (2018-10-01)

Evaluation of the Potency of the Pertussis Vaccine in Experimental Infection Model with <i>Bordetella pertussis</i>: Study of the Case of the Pertussis Vaccine Used in the Expanded Vaccination Program in Algeria
od: Khedidja Tahar djebbar, i dr.
Izdano: (2022-06-01)

A computational framework for modeling and studying pertussis epidemiology and vaccination
od: Paolo Castagno, i dr.
Izdano: (2020-09-01)

Pertussis, anti-Bordetella pertussis toxin, vaccination, and clinical surveillance
od: Amnuay Kleebayoon, i dr.
Izdano: (2023-01-01)

Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines
od: Kevin Markey, i dr.
Izdano: (2019-07-01)

Pertussis vaccination in mixed markets: Recommendations from the Global Pertussis Initiative
od: Amar J. Chitkara, i dr.
Izdano: (2020-07-01)

Pertussis in the Voronezh Region: Epidemiology and Vaccination
od: N. P. Mamchik, i dr.
Izdano: (2020-05-01)

Pertussis vaccination: problems, possible solutions
od: S. M. Kharit, i dr.
Izdano: (2020-06-01)

Influenza and pertussis vaccine uptake during pregnancy among Australian women in south‐east Queensland, Australia
od: Lucy Laurie, i dr.
Izdano: (2021-10-01)

Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection
od: Aapo Knuutila, i dr.
Izdano: (2023-12-01)

Pertussis Prevention: Reasons for Resurgence, and Differences in the Current Acellular Pertussis Vaccines
od: Susanna Esposito, i dr.
Izdano: (2019-07-01)

Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
od: Longhuan Ma, i dr.
Izdano: (2021-06-01)

Lessons from a mature acellular pertussis vaccination program and strategies to overcome suboptimal vaccine effectiveness
od: Ousseny Zerbo, i dr.
Izdano: (2022-07-01)

Influenza vaccines in healthy children.
od: Isaacs, D, i dr.
Izdano: (2005)

Pertussis deaths in New Zealand without community transmission—an infant immunity gap?
od: Peter B. McIntyre, i dr.
Izdano: (2023-08-01)

A survey of maternal pertussis vaccine uptake in England
od: H. McAuslane, i dr.
Izdano: (2014-04-01)

Varicella and herpes zoster hospitalizations before and after implementation of one-dose varicella vaccination in Australia: an ecological study
od: Anita E Heywood, i dr.

Comparative Evaluation of Recombinant and Acellular Pertussis Vaccines in a Murine Model
od: Kyu-Ri Kang, i dr.
Izdano: (2024-01-01)

Protective Activity and Safety of Acellular Pertussis Vaccine from Vaccine and Freshly Isolated Strain Bordetella pertussis
od: E. M. Zaitsev, i dr.
Izdano: (2017-04-01)

Epidemiological Rationale for Changing the Strategy and Tactics of Vaccination of Pertussis in Current Conditions
od: K. A. Subbotina, i dr.
Izdano: (2019-05-01)